Authors: George Rajna
Researchers at Tokyo Institute of Technology, University of Tsukuba, and colleagues in Japan have reported a promising hydrogen carrier in the form of hydrogen boride nanosheets.  So-called nanoenzymes are hot candidates for treatments called catalytic immunotherapy.  A recent study, affiliated with South Korea's Ulsan National Institute of Science and Technology (UNIST) has introduced a novel targeted drug delivery system in the fight against cancer. 
Comments: 69 Pages.
[v1] 2019-10-26 04:21:42
Unique-IP document downloads: 8 times
Vixra.org is a pre-print repository rather than a journal. Articles hosted may not yet have been verified by peer-review and should be treated as preliminary. In particular, anything that appears to include financial or legal advice or proposed medical treatments should be treated with due caution. Vixra.org will not be responsible for any consequences of actions that result from any form of use of any documents on this website.
Add your own feedback and questions here:
You are equally welcome to be positive or negative about any paper but please be polite. If you are being critical you must mention at least one specific error, otherwise your comment will be deleted as unhelpful.